NCT00885196 2020-12-22A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisNovartisPhase 2 Completed336 enrolled
NCT01490632 2019-09-27A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisEli Lilly and CompanyPhase 2 Completed271 enrolled 32 charts
NCT01107457 2019-09-24A Study in Participants With Moderate to Severe PsoriasisEli Lilly and CompanyPhase 2 Completed142 enrolled 45 charts
NCT02908347 2019-01-23Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis PatientsMetrioPharm AGPhase 2 Completed46 enrolled 24 charts
NCT02201524 2016-10-05Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisPfizerPhase 2 Terminated59 enrolled 18 charts
NCT01831466 2015-11-25Tofacitinib Ointment For Chronic Plaque PsoriasisPfizerPhase 2 Completed476 enrolled 33 charts